Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-26-053130
Filing Date
2026-04-30
Accepted
2026-04-30 17:02:41
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm261540d2_defa14a.htm DEFA14A 6809
2 GRAPHIC tm261540d2_defa14aimg1.jpg GRAPHIC 206969
3 GRAPHIC tm261540d2_defa14aimg2.jpg GRAPHIC 140529
  Complete submission text file 0001104659-26-053130.txt   486874
Mailing Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355 484-875-3192
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39202 | Film No.: 26926957
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)